Copeptin in the Differential Diagnosis of Dysnatremia in Hospitalized Patients
COMED
1 other identifier
observational
300
1 country
2
Brief Summary
Background: Hypo- and hypernatremia are common in hospitalized patients. The differential diagnosis of dysnatremia is challenging. Osmotically inadequate secretion of antidiuretic hormone (ADH) is the predominant mechanism in most dysnatremic disorders. ADH measurement is cumbersome. It is derived from a larger precursor peptide along with copeptin, which is a more stable peptide directly mirroring the production of ADH. Objective: To evaluate the additional value of copeptin to improve a currently used algorithm in the differential diagnosis of (A) severe hypoosmolar hypo- and (B) severe hypernatremia. Design: Prospective observational study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2011
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2011
CompletedStudy Start
First participant enrolled
October 1, 2011
CompletedFirst Posted
Study publicly available on registry
October 20, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedDecember 2, 2015
November 1, 2015
3.5 years
September 30, 2011
November 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
diagnostic accuracy of copeptin within hospital stay
diagnostic accuracy will be determined by receiver operated curve (ROC) analysis. The study is powered to detect a difference of copeptin levels between patients with partial central diabetes insipidus (DI) and patients with primary polydipsia.
participants will be followed for up to 1 year
Study Arms (1)
hospitalized patients
hospitalized patients with hyponatremia
Eligibility Criteria
hospitalized patients with severe hypo or hypernatremia
You may qualify if:
- hyponatremia \<125 or hypernatremia \>155 mmol/L
You may not qualify if:
- no informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Basel, Switzerlandlead
- Kantonsspital Aaraucollaborator
Study Sites (2)
Mirjam Christ-Crain
Basel, Basel, 4031, Switzerland
Beat Müller
Aarau, Canton of Aargau, Switzerland
Related Publications (2)
Sailer CO, Winzeler B, Nigro N, Bernasconi L, Mueller B, Christ-Crain M. Influence of Outdoor Temperature and Relative Humidity on Incidence and Etiology of Hyponatremia. J Clin Endocrinol Metab. 2019 Apr 1;104(4):1304-1312. doi: 10.1210/jc.2018-01507.
PMID: 30462243DERIVEDNigro N, Winzeler B, Suter-Widmer I, Schuetz P, Arici B, Bally M, Refardt J, Betz M, Gashi G, Urwyler SA, Burget L, Blum CA, Bock A, Huber A, Muller B, Christ-Crain M. Copeptin levels and commonly used laboratory parameters in hospitalised patients with severe hypernatraemia - the "Co-MED study". Crit Care. 2018 Feb 9;22(1):33. doi: 10.1186/s13054-018-1955-7.
PMID: 29422070DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mirjam Christ-Crain, MD, PhD
University Hospital, Basel, Switzerland
- PRINCIPAL INVESTIGATOR
Beat Müller, MD
Kantonsspital Aarau, University Hospital Basel
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 30, 2011
First Posted
October 20, 2011
Study Start
October 1, 2011
Primary Completion
April 1, 2015
Study Completion
April 1, 2015
Last Updated
December 2, 2015
Record last verified: 2015-11